Browse the evidence

An increasingly unhealthful lifestyle among the US population has led to an obesity epidemic.

Promoting healthier lifestyle choices is essential to combat the obesity epidemic.

There is confusion about the effects of low-fat foods and carbohydrate-rich diets on weight management.

Practitioners should clarify dietary recommendations to reduce confusion among clients.

Mendelian randomisation awaits confirmation with RCT and real-world data.

Further research is needed to confirm the findings regarding GLP-1RA and suicide attempts.

Future clinical trials with other incretin mimetics may further emphasize the importance of an obesity phenotype-based approach in treating HFpEF.

Clinicians should stay informed about upcoming trials that may validate obesity phenotype-based treatments.

Final proof of efficacy for incretin therapies on primary clinical liver outcomes may come from large database analyses.

Future studies should focus on analyzing large datasets to confirm the efficacy of incretin therapies for NAFLD.

Ingesting bicarbonate as a hydrogel product may provide an advantage in the marathon.

Explore the potential benefits of bicarbonate supplementation for marathon training.

Collagen supplements may be useful to reduce tendon and ligament injuries in volleyball.

Consider recommending collagen supplementation for volleyball athletes to potentially reduce injury risk.

Cautious use of tirzepatide is vital due to potential adverse effects and contraindications.

Healthcare providers should monitor patients closely for adverse effects when prescribing tirzepatide.

Further interventional studies involving humans are needed to better understand the role of soy isoflavones in PCOS.

More research is necessary to fully understand how soy isoflavones can be effectively used in treating PCOS.

Strategies in supporting health and performance over a player's career are encouraged.

Organizations should hire qualified nutrition professionals to support players' long-term health.

There is a need to dispel myths about weight-loss medications.

Educating patients and physicians about the realities of weight-loss medications can improve acceptance and usage.

Semaglutide's success in India will depend on affordability, rational prescribing, and integration into preventive care frameworks.

Efforts should focus on making semaglutide accessible and integrating it into broader health strategies.

Further investigations are warranted regarding the effects of GLP-1-based therapies on skeletal muscle.

Practitioners should advocate for more research to better understand the implications of GLP-1 therapies on muscle health.

The conference affirmed the need for a medically meaningful and actionable diagnosis of obesity.

Practitioners should focus on developing actionable diagnostic criteria for obesity.

There is a need for increased nutrition and obesity education.

Practitioners should enhance education efforts regarding nutrition and obesity.

It is important to avoid stigmatizing overweight and obesity in weight management.

Practitioners should be mindful of language and attitudes towards patients with overweight and obesity.

Physicians should persist in offering patients attention, support, and individualized treatment.

Practitioners should ensure they provide ongoing support and tailored treatment for patients.

US nutrition recommendations to limit fat intake have not prevented the increase in obesity and diabetes.

Practitioners should reconsider the effectiveness of low-fat dietary recommendations.

This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) discusses 30 common obesity myths, misunderstandings, and/or oversimplifications.

Clinicians should be aware of these myths to improve patient care.

Knowledge of the underlying science may assist the obesity medicine clinician improve the care of patients with obesity.

Clinicians should leverage scientific knowledge to enhance patient outcomes.

The scientific support for this CPS is based upon published citations, clinical perspectives of OMA authors, and peer review.

The CPS is grounded in credible scientific and clinical perspectives.

Impaired vitamin K2-dependent processes by some types of vegetable oils and medicines are proposed as a cause of cardiovascular disease, diabetes, and other lifestyle-related diseases.

Consideration of vitamin K2 status may be important in managing cardiovascular and metabolic health.

Clinical inertia results in type 2 diabetes not being effectively managed.

Family physicians should be aware of the factors contributing to clinical inertia in T2D management.

Guidelines for antidiabetic drugs should provide case studies and clinical examples.

Improving guidelines with practical examples may enhance their application in clinical settings.